Bakker J M, Broug-Holub E, Kroes H, van Rees E P, Kraal G, van Iwaarden J F
Department of Cell Biology and Immunology, Faculty of Medicine, Vrije Universiteit, Amsterdam, The Netherlands.
Immunology. 1998 Jul;94(3):304-9. doi: 10.1046/j.1365-2567.1998.00518.x.
Alveolar macrophages (AM) are important in the regulation of immune responses in the lung, through their role as scavenger cells and through the production of many bioactive factors. Because in early infancy pulmonary infections are a recurrent problem, we studied the postnatal functional maturation of AM in a rat model. AM were isolated from rat lungs by bronchoalveolar lavage at several time intervals after birth and tested for their ability to ingest Escherichia coli in the presence of surfactant protein A (SP-A). Furthermore, their capacity to produce nitric oxide (NO) and interleukin-1 beta (IL-1 beta) after in vitro lipopolysaccharide (LPS) stimulation was analysed, as well as their capacity to downregulate proliferation of T cells from both mature and neonatal rats. SP-A-mediated phagocytosis of E. coli by AM was reduced in 14-day-old neonatal rats, as compared with mature rats (P < or = 0.05). Also the IL-1 beta production by rat AM after LPS stimulation was impaired at 14 days of age, as compared with IL-1 beta production by AM from mature rats (P < or = 0.05). In contrast, the LPS-induced NO production by rat AM as well as the capacity to inhibit T-cell proliferation were well developed at all ages tested. In conclusion, during postnatal development the rat AM is functionally immature, with respect to phagocytosis and secretion of inflammatory mediators. These differences may underly the enhanced susceptibility to pulmonary infections as found in human neonates.
肺泡巨噬细胞(AM)在肺部免疫反应调节中起着重要作用,它们作为清除细胞并通过产生多种生物活性因子来发挥作用。由于在婴儿早期肺部感染是一个反复出现的问题,我们在大鼠模型中研究了AM出生后的功能成熟情况。在出生后的几个时间间隔,通过支气管肺泡灌洗从大鼠肺中分离出AM,并检测它们在表面活性蛋白A(SP-A)存在下摄取大肠杆菌的能力。此外,分析了它们在体外脂多糖(LPS)刺激后产生一氧化氮(NO)和白细胞介素-1β(IL-1β)的能力,以及它们下调成熟大鼠和新生大鼠T细胞增殖的能力。与成熟大鼠相比,14日龄新生大鼠中AM介导的SP-A对大肠杆菌的吞噬作用降低(P≤0.05)。同样,与成熟大鼠的AM产生的IL-1β相比,14日龄大鼠的AM在LPS刺激后产生IL-1β的能力受损(P≤0.05)。相比之下,在所有测试年龄,大鼠AM由LPS诱导的NO产生以及抑制T细胞增殖的能力都发育良好。总之,在出生后的发育过程中,大鼠AM在吞噬作用和炎症介质分泌方面功能不成熟。这些差异可能是人类新生儿对肺部感染易感性增强的原因。